V Vijay Sangwan π Mover β 28.62K Points π Biopharmaceutics and Pharmacokinetic Q. Poor bioavailability means poor aqueous solubility. (A) True (B) False (C) none (D) all ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) True
R Rakesh Kumar π Hard Worker β 28.44K Points π Biopharmaceutics and Pharmacokinetic Q. The time period for which the plasma concentration of drug remains above minimum effective concentration is known as ______________ (A) Onset of time (B) Onset of action (C) Duration of drug of action (D) Therapeutic range ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (C) Duration of drug of action
A Admin π Coach β 38.23K Points π Biopharmaceutics and Pharmacokinetic Q. In vitro determination of bioavailability by dissolution rate is not the best way to determine therapeutic efficacy. (A) True (B) False (C) none (D) all ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (B) False
V Vijay Sangwan π Mover β 28.62K Points π Biopharmaceutics and Pharmacokinetic Q. Therapeutic response is based on observing the clinical response to a drug formulation. (A) True (B) False (C) none (D) all ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) True
V Vijay Sangwan π Mover β 28.62K Points π Biopharmaceutics and Pharmacokinetic Q. Which of the following is not measured in acute pharmacological response study? (A) ECG (B) EEG (C) Pupil diameter (D) Serum drug level ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (D) Serum drug level
R Rakesh Kumar π Hard Worker β 28.44K Points π Biopharmaceutics and Pharmacokinetic Q. Which of the following will not be a parameter that should be examined for urinary excretion data? (A) (dXu/dt) max (B) (tu)max (C) Xu (D) Cmax ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (D) Cmax
R Rakesh Kumar π Hard Worker β 28.44K Points π Biopharmaceutics and Pharmacokinetic Q. The urinary excretion of the unchanged drug is directly proportional to the plasma concentration of a drug. (A) True (B) False (C) none (D) all ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) True
P Praveen Singh π Tutor III β 36.81K Points π Biopharmaceutics and Pharmacokinetic Q. What is the equation for bioavailability? (A) [AUC]std Dstd τtest / [AUC]test Dtest τstd (B) [AUC]test Dtest τstd / [AUC]std Dstd τtest (C) [AUC]test Dstd τtest / [AUC]std Dtest τstd (D) 1 / [AUC]std Dtest τstd ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (C) [AUC]test Dstd τtest / [AUC]std Dtest τstd
S Shiva Ram π Master β 30.44K Points π Biopharmaceutics and Pharmacokinetic Q. Which of the following is not an important parameter of plasma level time studies? (A) Cmax (B) Tax (C) The area under the plasma level-time curve (D) Steady state level ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (D) Steady state level
S Shiva Ram π Master β 30.44K Points π Biopharmaceutics and Pharmacokinetic Q. Which of the following is the pharmacodynamics method of studying bioavailability? (A) Acute pharmacologic response (B) Plasma-level time studies (C) Urinary excretion studies (D) Stool excretion studies ποΈ Show Answer π¬ Discuss π Share β‘Menu β Correct Answer: (A) Acute pharmacologic response